| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Laboratorio de Fisiología y Biología Molecular (C.P.C., R.P., E.A.), Departamento de Biología, Facultad de Ciencias Exactas Naturales, Universidad de Buenos Aires, Argentina; and Max-Planck Institute of Psychiatry (M.P.P., U.R., J.M.H.M.R., G.K.S., F.H.), Clinical Institute, Kraepelinstr, 210, 80804 Munich, Germany
Address all correspondence and requests for reprints to: Dr. Eduardo Arzt, Laboratorio de Fisiología y Biología Molecular, Department de Biología, Facultad Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria-Pabellon II, 1428 Buenos Aires, Argentina. E-mail: earzt{at}bg.fcen.uba.ar
Functional interaction between the immune and neuroendocrine systems is mediated by humoral mediators, neurotransmitters, and cytokines, including TRH and PRL. We examined the role of neuroendocrine changes, particularly TRH and PRL, during the T cell-dependent immune response. After immunization of rats with sheep red blood cells (SRBC, a T cell-dependent antigen), an increase of hypothalamic TRH messenger RNA (mRNA) was observed at 424 h post immunization, in contrast to the decrease observed after treatment with lipopolysaccharide (LPS). During the above period, with SRBC, there was an increase in pituitary TRH receptor mRNA and plasma PRL levels but no changes in TSH and GH. Also, in contrast to the early corticosterone peak induced by LPS, the activation of the hypothalamic-pituitary-adrenocortical suppressive response appears in a late phase, 57 days after SRBC. Intracerebroventricular injection of antisense oligonucleotide complementary to rat TRH mRNA in conscious freely-moving rats immunized with SRBC resulted in a significant inhibition of specific antibody production and a concomitant inability to produce the peak in plasma PRL levels. These studies demonstrate, for the first time, that the T cell-dependent immune response is critically dependent on the early activation of TRH and PRL and that the neuroendocrine changes occurring during it are profoundly different from those occurring during the T cell-independent and inflammatory responses (LPS model).
This article has been cited by other articles:
![]() |
D. Refojo, C. Echenique, M. B. Muller, J. M. H. M. Reul, J. M. Deussing, W. Wurst, I. Sillaber, M. Paez-Pereda, F. Holsboer, and E. Arzt Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas PNAS, April 26, 2005; 102(17): 6183 - 6188. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Straub, J. Georgi, K. Helmke, P. Vaith, and B. Lang In polymyalgia rheumatica serum prolactin is positively correlated with the number of typical symptoms but not with typical inflammatory markers Rheumatology, April 1, 2002; 41(4): 423 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text] |
||||
![]() |
C. P. Castro, A. C. Nagashima, M. P. Pereda, V. Goldberg, A. Chervin, P. Largen, U. Renner, G. K. Stalla, and E. Arzt The gp130 Cytokines Interleukin-11 and Ciliary Neurotropic Factor Regulate through Specific Receptors the Function and Growth of Lactosomatotropic and Folliculostellate Pituitary Cell Lines Endocrinology, May 1, 2000; 141(5): 1746 - 1753. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |